Cardio Diagnostics Holdings, Inc. (CDIO)
1.87
+0.01
(+0.54%)
USD |
NASDAQ |
Oct 09, 16:00
1.86
-0.01
(-0.53%)
After-Hours: 20:00
Cardio Diagnostics Holdings Net Income (Quarterly) : -1.502M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.502M |
| March 31, 2026 | -1.788M |
| December 31, 2025 | -1.465M |
| September 30, 2025 | -1.714M |
| June 30, 2025 | -1.683M |
| March 31, 2025 | -1.635M |
| December 31, 2024 | -1.519M |
| September 30, 2024 | -1.413M |
| June 30, 2024 | -1.288M |
| March 31, 2024 | -4.164M |
| December 31, 2023 | -1.389M |
| Date | Value |
|---|---|
| September 30, 2023 | -1.932M |
| June 30, 2023 | -4.023M |
| March 31, 2023 | -1.033M |
| December 31, 2022 | -4.148M |
| September 30, 2022 | -1.151M |
| June 30, 2022 | -0.842M |
| March 31, 2022 | -0.2901M |
| December 31, 2021 | -0.1441M |
| September 30, 2021 | -0.0003M |
| June 30, 2021 | -0.0004M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -17.80M |
| Exicure, Inc. | -1.121M |
| Century Therapeutics, Inc. | -34.55M |
| Absci Corp. | -33.21M |
| Celularity, Inc. | 0.675M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0054M |
| Total Expenses (Quarterly) | 1.507M |
| EPS Diluted (Quarterly) | -0.5073 |
| Enterprise Value | 0.3173M |
| Gross Profit Margin (Quarterly) | -824.1% |
| Profit Margin (Quarterly) | -27.81K% |
| Earnings Yield | -155.9% |
| Normalized Earnings Yield | -155.86 |